NVCR insider trading
Open-market stock trades by NovoCure (NVCR) executives and directors: who bought or sold, how many shares, at what price and when.
NVCR insider trades
| Date | Insider | Role | Trade | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jun 4, 2026 | Leonard Frank X | Chief Executive Officer | Sell | 34,273 | $17.93 | $614.63K |
| Jun 2, 2026 | LEUNG GABRIEL | director | Sell | 2,945 | $15.77 | $46.44K |
| Jun 2, 2026 | Stafford Kristin | director | Sell | 2,945 | $15.77 | $46.44K |
| Jun 2, 2026 | Ocean Allyson J | director | Sell | 2,945 | $15.77 | $46.44K |
| Jun 2, 2026 | Scannell Timothy J | director | Sell | 2,945 | $15.77 | $46.44K |
| Jun 2, 2026 | HILLEMAN JERYL L | director | Sell | 2,945 | $15.77 | $46.44K |
| Jun 2, 2026 | VERNON W ANTHONY | director | Sell | 2,945 | $15.77 | $46.44K |
| Jun 2, 2026 | Hung David | director | Sell | 2,945 | $15.77 | $46.44K |
| Mar 4, 2026 | Leupin Nicolas | Former Chief Medical Officer | Sell | 1,100 | $13.31 | $14.64K |
| Mar 4, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | Sell | 6,412 | $13.31 | $85.31K |
| Mar 4, 2026 | Brackmann Christoph | Chief Financial Officer | Sell | 6,412 | $13.31 | $85.31K |
| Mar 4, 2026 | Leonard Frank X | Chief Executive Officer | Sell | 5,607 | $13.31 | $74.60K |
| Mar 4, 2026 | Paravasthu Mukund | Chief Operating Officer | Sell | 5,377 | $13.31 | $71.54K |
| Mar 5, 2026 | Paravasthu Mukund | Chief Operating Officer | Sell | 43,246 | $13.77 | $595.67K |
| Mar 4, 2026 | Puri Michal Nath | Chief Human Resources Officer | Sell | 1,100 | $13.31 | $14.64K |
| Mar 3, 2026 | DOYLE WILLIAM F | Executive Chairman | Sell | 50,557 | $12.79 | $646.45K |
| Mar 3, 2026 | DOYLE WILLIAM F | Executive Chairman | Sell | 21,330 | $13.43 | $286.44K |
| Feb 27, 2026 | Paravasthu Mukund | Chief Operating Officer | Sell | 1,555 | $13.66 | $21.25K |
| Mar 2, 2026 | Paravasthu Mukund | Chief Operating Officer | Sell | 408 | $13.49 | $5.51K |
| Feb 27, 2026 | Leupin Nicolas | Former Chief Medical Officer | Sell | 1,029 | $13.66 | $14.06K |
| Mar 2, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | Sell | 3,272 | $13.33 | $43.61K |
| Feb 27, 2026 | Weinberg Uri | Chf Medical and Innovation Ofr | Sell | 7,461 | $13.84 | $103.26K |
| Feb 27, 2026 | Puri Michal Nath | Chief Human Resources Officer | Sell | 1,441 | $13.66 | $19.69K |
| Mar 2, 2026 | Leonard Frank X | Chief Executive Officer | Sell | 7,232 | $13.49 | $97.58K |
| Feb 27, 2026 | Leonard Frank X | Chief Executive Officer | Sell | 9,734 | $13.66 | $133.00K |
| Sep 5, 2025 | Cordova Ashley | Chief Executive Officer | Buy | 81,550 | $12.22 | $996.86K |
| Jul 29, 2025 | Brackmann Christoph | Chief Financial Officer | Buy | 5,000 | $11.50 | $57.50K |
| Jul 29, 2025 | Brackmann Christoph | Chief Financial Officer | Buy | 5,000 | $11.60 | $58.00K |
| Jul 29, 2025 | Brackmann Christoph | Chief Financial Officer | Buy | 10,000 | $11.63 | $116.30K |
- NVCR insiders bought $1.23M and sold $3.25M in open-market trades over their last 29 filings.
Updated 2026-11-03 12:36 UTC